Semler Scientific
Semler Scientific, Inc. is a medical technology company based in San Jose, California, focused on developing, manufacturing, and marketing proprietary products designed to assist healthcare providers in evaluating and treating chronic diseases. Founded in 2007, the company offers innovative solutions such as QuantaFlo, a quick in-office blood flow test that enables healthcare providers to assess patients' vascular conditions effectively. Semler's products cater to a diverse range of medical professionals, including cardiologists, nephrologists, and primary care physicians, as well as healthcare insurance plans and integrated delivery networks. The company aims to enhance the clinical effectiveness and efficiency of healthcare delivery while ensuring that providers can fully capture reimbursement for their services. With a commitment to advancing medical risk assessment, Semler Scientific is recognized for its contributions to improving patient care in the United States.
Monarch Medical Technologies
Debt Financing in 2022
Monarch Medical Technologies is a medical technology company that specializes in computer-based solutions for healthcare institutions, primarily focusing on glycemic management. The company has developed the EndoTool Glucose Management System, a software application designed to enhance inpatient glycemic control by replacing traditional manual insulin dosing methods with a more intuitive, predictive approach. This FDA-cleared system integrates seamlessly with major electronic medical record (EMR) systems, providing tailored management for both critical and non-critical care patients. In addition to the glucose management system, Monarch also offers EndoTool Analytics, which helps healthcare organizations identify and analyze performance trends related to glycemic control, enabling improved clinical outcomes. The company further supports its offerings with clinical consulting services, contributing to its mission of optimizing patient care in diverse healthcare settings. Monarch Medical Technologies is based in the United States.
Synaps Dx
Corporate Round in 2022
Synaps Dx is a privately held company focused on the research, development, and commercialization of diagnostics for neurodegenerative disorders and conditions, including Alzheimer’s Disease.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.